Rising Academic Contributions to Drug Development: Evidence of Vigor or Trauma?

Michael S. Kinch, Caitlin Horn, Zachary Kraft, Tyler Schwartz

Research output: Contribution to journalReview articlepeer-review

Abstract

We analyzed therapeutic areas most commonly targeted by academia since 2001, finding a domination of certain oncology and infectious diseases. These findings raise important questions about whether this trend reflects an expanded opportunity arising from academic research or a troubling sign of an industry struggling with the challenges of innovation.

Original languageEnglish
Pages (from-to)1427-1429
Number of pages3
JournalACS Pharmacology and Translational Science
Volume3
Issue number6
DOIs
StatePublished - Dec 11 2020

Keywords

  • academic
  • biotechnology
  • founder
  • inventor
  • oncology
  • patent
  • pharmaceutical industry

Fingerprint

Dive into the research topics of 'Rising Academic Contributions to Drug Development: Evidence of Vigor or Trauma?'. Together they form a unique fingerprint.

Cite this